AskBorsa

Macro Group Pharmaceuticals - Macro Capital S.A.E results, Q3 2026

Net profit, assets, equity and cash flow for Q3 2026, against the same period a year earlier, from the published financial statements. Consolidated figures cover the 9 months to 30 September 2026; the comparison is with the same months a year earlier, from the same disclosure.

Net profit180 millionEGP · +73.5% vs the same period a year earlier
Total assets1.43 billionEGP · +84.3% vs the same period a year earlier
Shareholders' equity918 millionEGP · +373.3% vs the same period a year earlier
Operating cash flow81.75 millionEGP · +26.5% vs the same period a year earlier

In short

  • Macro Group Pharmaceuticals - Macro Capital S.A.E's net profit for Q3 2026 was about 180 million EGP, up +73.5% from 104 million EGP in Q3 2025.
  • Total assets at the end of Q3 2026 were about 1.43 billion EGP, and shareholders' equity about 918 million EGP.
  • Operating cash flow for Q3 2026 was positive at 81.75 million EGP.
Source: the Q3 2026 financial statements, read from the published report

Key lines against the same period a year earlier

This periodQ3 2025Change
Net profit180 million104 million+73.5%
Gross profit655 million464 million+41.1%
Total assets1.43 billion778 million+84.3%
Total liabilities515 million584 million−11.7%
Shareholders' equity918 million194 million+373.3%
Operating cash flow81.75 million64.63 million+26.5%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Consolidated figures cover the 9 months to 30 September 2026; the comparison is with the same months a year earlier, from the same disclosure.

Official report (PDF)All of Macro Group Pharmaceuticals - Macro Capital S.A.E's statements, five yearsAsk the AI analyst about MCRO

Macro Group Pharmaceuticals - Macro Capital S.A.E's Fiscal year 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for Macro Group Pharmaceuticals - Macro Capital S.A.E